Immunological Change and the Single Nucleotide Polymorphism (SNP) in Children With Irritable Bowel Syndrome (IBS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01131442
Recruitment Status : Unknown
Verified May 2010 by Chang Gung Memorial Hospital.
Recruitment status was:  Recruiting
First Posted : May 27, 2010
Last Update Posted : May 27, 2010
Information provided by:
Chang Gung Memorial Hospital

Brief Summary:
Currently, the pathophysiology of Irritable bowel syndrome( IBS) remains unclear . The purpose of this study is want to investigate the immunological changes in the children with IBS.

Condition or disease
Irritable Bowel Syndrome Children

Detailed Description:
Irritable bowel syndrome (IBS) is a highly prevalent functional gastrointestinal disorder.Many children suffered from this disease and had impact on their daily life. However, the underlying pathophysiologic mechanisms remain to be elucidate. Dysregulation of the gut immune system is considered an important pathophysiology. We want to investigate the immunological changes in the IBS children.

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case Control
Time Perspective: Cross-Sectional
Study Start Date : November 2008

The patient group
healthy control group

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   5 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
out patient clinics in the hospital

Inclusion Criteria:

  • (5-18y/o) with IBS,
  • All patients had chronic or relapsing symptoms of IBS consistent with the ROME II criteria

Exclusion Criteria:

  • A history of psychologic disorders, probiotics, anti-inflammatory, analgesic, or immunosuppressive medication (nonsteroidal anti-inflammatory drugs, steroids) within the past 3 months were excluded

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01131442

Chang Gung Memeorial Hospital Recruiting
Keelung, Taiwan
Contact: Man-Chin Hua, M.D.    886-2-24313131 ext 2626   
Principal Investigator: Man-Chin Hua Hua, M.D.         
Sponsors and Collaborators
Chang Gung Memorial Hospital

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Chang Gung Memorial Hospital Identifier: NCT01131442     History of Changes
Other Study ID Numbers: CMRPG270371
First Posted: May 27, 2010    Key Record Dates
Last Update Posted: May 27, 2010
Last Verified: May 2010

Keywords provided by Chang Gung Memorial Hospital:

Additional relevant MeSH terms:
Irritable Bowel Syndrome
Pathologic Processes
Colonic Diseases, Functional
Colonic Diseases
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases